Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Edessa
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict76/ 100
Grade C · #73Edessa
Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest is a different drug.
Visit EdessaThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 76/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Edessa still earns its place — a six-month committer, or anyone willing to click past the homepage to the table that states the real monthly rate.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results80
92
Real-world results80
97Price honesty64
97
Price honesty64
96Prescriber access80
96
Prescriber access80
88Formulary choice80
88
Formulary choice80
95Cancellation fairness74
95
Cancellation fairness74
93Member support82
93
Member support82
Price, coverage & features
| Metric | CoreAge Rx | Edessa |
|---|---|---|
| Verdict Score | 94/100 | 76/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $179/mo injectable (compounded; $135 only on a 6-month prepay) |
| Tirzepatide | $149/mo | $239/mo (compounded; $209 only on a 6-month prepay) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Edessa
What we like
- Each product page carries a plain three-rung "PLAN / PER MONTH" table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
- The program is stated as all-inclusive — provider consultation, medication, free expedited shipping, ongoing check-ins and 24/7 clinical support — and is HSA and FSA eligible
The caveats
- The homepage leads with "Start for just $135", which is a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three homepage cards quote the six-month rung, so the real monthly rates appear only after a click
- Its own Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation" — and an LLC is not a corporation
- "Join 100,000+ successful GLP-1 patients" carries no source, and the advertised money-back guarantee's terms are on no marketing page
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
A six-month committer, or anyone willing to click past the homepage to the table that states the real monthly rate.
Visit Edessa Read the full Edessa review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Edessa does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.